One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials
Subodh Verma MD, PhD a, Javed Butler MD b, Barry A. Borlaug MD c, Melanie Davies MD d, Dalane W. Kitzman MD e, Sanjiv J. Shah MD f, Mark C. Petrie MD g, Eric Barros MD h, Cecilia Rönnbäck MD, PhD h, Lene Sommer Vestergaard MSc h, Morten Schou MD, PhD i, Justin A. Ezekowitz MBBCh, MSc j, Kavita Sharma MD k, Shachi Patel PhD l, Khaja M. Chinnakondepalli MS l, Mikhail N. Kosiborod MD m, STEP-HFpEF Trial Committees and Investigators
Incretin-Based Therapies in Women With Obesity-Related HFpEF: Time to STEP Into a Paradigm of Integrated Care
John W. Ostrominski MD a b, Anuradha Lala MD c
The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering: OCEAN(a)-DOSE Extension Period Results
Michelle L. O’Donoghue MD, MPH a, Robert S. Rosenson MD b, J. Antonio G. López MD c, Norman E. Lepor MD d, Seth J. Baum MD e f, Elmer Stout MD g, Daniel Gaudet MD, PhD h, Beat Knusel PhD c, Julia F. Kuder MA a, Sabina A. Murphy MPH a, Huei Wang PhD c, You Wu PhD c, Trupti Shah MD, MPH c, Jingying Wang PhD c, Tomasz Wilmanski MPH, PhD c, Winnie Sohn PhD c, Helina Kassahun MD c, Marc S. Sabatine MD, MPH a, OCEAN(a)-DOSE Trial Investigators
Olpasiran Pharmacodynamic Study: Ensuring We Go a Mile Deep But More Than an Inch Wide
Jared Alexander Spitz MD a, Anandita Agarwala MD b
Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization
Mario Enrico Canonico MD, PhD a b, Cecilia C. Low Wang MD a c, Judith Hsia MD a b, E. Sebastian Debus MD, PhD d, Mark R. Nehler MD a e, Manesh R. Patel MD f, Sonia S. Anand MD g, Joseph Ycas PhD a, Warren H. Capell MD a c, Eva Muehlhofer MD h, Lloyd P. Haskell MD, MBA i, Scott D. Berkowitz MD a b j, Rupert Bauersachs MD k l, Marc P. Bonaca MD, MPH a b
Frailty in Peripheral Artery Disease Patients Undergoing Revascularization: There Is Strength in Antithrombotic Therapy
Umberto Campia MD, MS a b, Giovanni Scimeca MD b
Deep Learning-Based Electrocardiogram Analysis Predicts Biventricular Dysfunction and Dilation in Congenital Heart Disease
Joshua Mayourian MD, PhD a ∗, Addison Gearhart MD a ∗, William G. La Cava PhD b, Akhil Vaid MD c, Girish N. Nadkarni MD c, John K. Triedman MD a, Andrew J. Powell MD a, Rachel M. Wald MD d, Anne Marie Valente MD a, Tal Geva MD a, Son Q. Duong MD c e, Sunil J. Ghelani MD a
Democratizing Congenital Heart Disease Management: The Potential for AI-Enabled Care and Necessary Future Directions
Sneha S. Jain MD a, Pierre Elias MD b c, Daniel E. Clark MD, MPH a
Structural Cardiac Interventions in Patients With Heart Failure: JACC Scientific Statement
Rebecca T. Hahn MD a b, JoAnn Lindenfeld MD c, Scott D. Lim MD d e, Michael J. Mack MD f, Daniel Burkhoff MD, PhD b
Treatment of Transcatheter Aortic Valve Thrombosis: JACC Review Topic of the Week
Rik Adrichem MD a, Josep Rodes Cabau MD, PhD b, Roxana Mehran MD, PhD c, Duk-woo Park MD, PhD d, Jurrien M. Ten Berg MD, PhD e f, Ole de Backer MD, PhD g, Christian Hengstenberg MD, PhD h, Ricardo P.J. Budde MD, PhD i, George D. Dangas MD, PhD c, Raj Makkar MD j, Nicolas M. Van Mieghem MD, PhD a
Catheter Ablation for Atrial Fibrillation in Advanced Heart Failure: Can We Trust the CASTLE-HTx Trial?
Nathan Mewton MD, PhD a, Florian Zores MD b, Milton Packer MD c d
Effect of Semaglutide on Epicardial Adipose Tissue in Type 2 Diabetes: Insights From the STOP (Semaglutide Treatment effect On coronary atherosclerosis Progression) Randomized Trial
Venkat Sanjay Manubolu MD, MPH, Suvasini Lakshmanan MD, MS, April Kinninger MPH, Khadije Ahmad MBBS, Shriraj Susarla BS, Hoon J. Seok BS, Sajad Hamal MSc, Suraj Dahal MD, Sion K. Roy MD, Matthew J. Budoff MD
The Anterior Mitral Valve Leaflet Prolapse as a Key to Diagnosis of ALCAPA Syndrome
Taida Ivanauskiene MD a b, Gitana Zuoziene MD, PhD a b, Diana Zakarkaite MD, PhD a b, Virgilijus Tarutis MD, PhD a b, Sigita Glaveckaite MD, PhD a b
